Organization: Health Canada
Year: 2022
Month: August
Request Number: A-2021-001245
Request Summary: The Health Canada Generic Submissions Under Review List, an Abbreviated New Drug Submission (ANDS) for degarelix acetate was submitted on or after October 1, 2018. All records containing information regarding the evidence of clinical effectiveness of the new drug for the purpose and under the conditions of use recommended, as described in paragraph C.08.002(2)(h) of the Food and Drug Regulations.
Disposition: Disclosed in part
Number of pages: 23